Member Info for Phil7390

Wow, how positive is that article? "End of the thermometer", "has become the first". This is great news, and the spotlight is clearly very firmly on the NHS now to modernise and save money.

On the other hand, results ARE due some time in the next seven days, and if they are good then 20p is in the bag. You've gotta ask yourself one question: "Do I feel lucky?" Well, do ya, punk? ;)

I'm in for a five figure sum and I'm down 22%, not in the least worried and holding. Next share option for directors is not available until SP is 20p. My long term target is well north of 50p for this one. AIM shares will tend to drift down and down between news, and next rns will bump up to the next level on good news.

I'm willing to be corrected, but my notes say Woodford has a 33% holding, so not a small percentage.

"The Company also reports that headline data from the recently conducted pilot clinical study with OXPzeroTM Naproxen (OXP005) will be available by the end of July 2015" So, another RNS expected in the next two weeks.

New trial announced at St James, Leeds. George Freeman MP, Minister for Life Sciences, said: "This latest trial has the potential to bring huge benefits to patients and staff and highlights why the NHS is the ideal place to test new digital technologies. We are committed to supporting new medical innovations which is why we invest £1 billion a year in the National Institute for Health Research, helping to introduce the latest innovations into the healthcare system as quickly as possible."

that should have read 2017 btw!

FWIW, the directors have substantial bonuses due if they get the share price to be above 18p for 6 months by 201, i.e not just reach 18p but stay above 18p for 6 months. That's a minmimum SP target for me.

Same will happen here on news I'm sure. Woodford has a similar holding in both, he's rarely wrong with that level of investment, so hold tight. RENE had good news today, another day it will be OXPs turn. GLA.

Not complaining, tripled my holding there today!

Jinxed that cmc! 15.75% now.

We've been in the doldrums for far too long, some good news and SP movement would be welcome!

Not! Yahoo Finance is reporting several new items on Toumaz as "Today" when they were from 7th January. 1/7/15 does not equal 7/1/15, but any news is good eh?

Seriously bad English in the conclusion of that report, I'd read it as meaning there is potential is self monitoring devices as tech improves. However, you make a valid point. I was admitted to hospital two weeks ago (coincidentally for BP off the charts at 220/122) and despite having been a drive/walk in at the GP I was taken by ambulance and then ferried around the hospital A&E and GPAU on trollies and wheelchairs. I could have walked, but no-one was going to allow me to while they were responsible for me, so CYA is, understandably, endemic in the NHS. I had BP tested no less than 8 times, along with other vitals, by various nurses and doctors, so my belief in the benefits of SensiumVitals is as robust as ever!

If this is an alternate tech to Toumaz but not really competing in the same market space, it could actually have a positive effect - can you imagine the situation where patients have access to more info on their Google Watch than their medical team? There would have to be some pressure on the NHS to update its systems. It would be great news though if there were some tie in with Google here re the vitals monitoring, but yes, there should be an RNS if that were the case. The previous RNS was very specifically for Cast-for-audio.

Is this our tech or Google own? Is this part of the tie up with Google? This is perhaps make or break for SensiumVitals.

What was interesting to me, and what shines through on the Toumaz website now, i sthat while I had been considering Toumaz as a company with two relatively diverse revenue streams, SensiumVitals and DAB radio, I appear to have been missing a trick! As Mt Hannon states, they actually have three. Connected audio is the third, and hence the linkup with Google. Unbelievably, this third market is also on the cusp of huge expansion with Toumaz perfectly positioned to exploit this. Three diverse but related revenue streams each with state of the art products perfectly poised in burgeoning markets. Toumaz, and Mr Toumazou, really have the Midas touch.

Very positive comments in there. Tim Kelsey, National Director for Patients and Information, said: “The NHS is embracing the offering of digital services to patients, with more than 55 million patients set to benefit from progress. “As well as giving patients more choice and control, better use of technology can save money."

Good review of what the co-development agreement is all about. http://www.trustedreviews.com/opinions/what-is-google-cast-for-audio Consider that the Toumaz DAB chips have tech to get best reception and lowest power consumption for DAB radio and you can see why Goggle would be interested in Toumaz for co-development of cast-for-audio devices.

“Looking longer term, the group has been assessing potential opportunities in the home health sector,” they write. “Opportunities may exist to introduce tailored SensiumVitals solutions for patients recently discharged from hospital or those with long term chronic conditions such as congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD) or diabetes. However, in the short term, the company’s key priority is to build the SensiumVitals business in the hospital market.” + Google Watch or Google Fit = ££££